anmelden
BX Swiss TOP 30 CHF
1.375,85
PKT
-15,97
PKT
-1,15
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.10.10 | Roche buy | Goldman Sachs Group Inc. | |
| 08.10.10 | Straumann hold | Vontobel Research | |
| 08.10.10 | Givaudan hold | Vontobel Research | |
| 11.10.10 | Novartis buy | SEB AG | |
| 07.10.10 | Zurich Insurance halten | Independent Research GmbH | |
| 07.10.10 | Roche kaufen | Hamburger Sparkasse AG (Haspa) | |
| 07.10.10 | Logitech buy | Vontobel Research | |
| 07.10.10 | Novartis buy | Vontobel Research | |
| 07.10.10 | Zurich Insurance buy | Vontobel Research | |
| 07.10.10 | Novartis buy | UBS AG | |
| 05.10.10 | UBS buy | Vontobel Research | |
| 05.10.10 | Novartis buy | Vontobel Research | |
| 06.10.10 | UBS kaufen | Independent Research GmbH | |
| 04.10.10 | Novartis neutral | UBS AG | |
| 01.10.10 | UBS kaufen | Independent Research GmbH | |
| 01.10.10 | Givaudan hold | Vontobel Research | |
| 01.10.10 | UBS buy | Vontobel Research | |
| 01.10.10 | Holcim overweight | HSBC | |
| 01.10.10 | Novartis buy | Vontobel Research | |
| 01.10.10 | Kühne + Nagel International buy | Vontobel Research | |
| 01.10.10 | Nestlé halten | Der Aktionärsbrief | |
| 01.10.10 | Logitech neutral | Banc of America Securities-Merrill Lynch | |
| 30.09.10 | UBS buy | Vontobel Research | |
| 30.09.10 | Novartis buy | Vontobel Research | |
| 30.09.10 | ABB (Asea Brown Boveri) hold | Vontobel Research | |
| 30.09.10 | Holcim buy | Société Générale Group S.A. (SG) | |
| 29.09.10 | UBS buy | SEB AG | |
| 28.09.10 | Sonova hold | Vontobel Research | |
| 28.09.10 | Adecco SA hold | Société Générale Group S.A. (SG) | |
| 27.09.10 | Kühne + Nagel International buy | Vontobel Research | |
| 27.09.10 | Nestlé buy | Vontobel Research | |
| 27.09.10 | Adecco SA buy | Vontobel Research | |
| 27.09.10 | Swiss Life neutral | Goldman Sachs Group Inc. | |
| 24.09.10 | Adecco SA buy | Vontobel Research | |
| 24.09.10 | Novartis buy | Vontobel Research | |
| 23.09.10 | Novartis overweight | Morgan Stanley | |
| 23.09.10 | Adecco SA buy | Vontobel Research | |
| 24.09.10 | Novartis buy | Nomura | |
| 23.09.10 | Novartis neutral | Goldman Sachs Group Inc. | |
| 23.09.10 | Novartis kaufen | Independent Research GmbH |